Loading data for AQST — first visit, this takes a few seconds.
Aquestive Therapeutics In... (AQST)
: AQST
· Real-Time Price · USD
n/a
n/a (n/a)
At close: Invalid Date
4.55
-0.87%
After-hours: 7:51 PM
Aquestive Therapeutics Inc. (AQST) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | 54.09M |
| Net Income (ttm) | -78.23M |
| Beta | 1.43 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | -8.05 |
| P/B (ttm) | -10.18 |
| P/S (ttm) | 10.65 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | NaN |
| Avg. Volume (20D) | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AQST
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film ...
Sector Healthcare
IPO Date Jul 25, 2018
Employees 147
Stock Exchange NasdaqGM
Ticker Symbol AQST
Website https://www.aquestive.com
Financial Performance
In 2025, Aquestive Therapeutics's revenue was 44.55M, a decrease of -22.61% compared to the previous year's 57.56M. Earnings were -83.78M, an increase of 89.83%.
Financial Statements